Out of them, STAT3 (signal transducer and activator of transcription 3) inhibitors, flavonoid compounds extracted from the seeds of Silybum marianum, could play a role in reducing the toxicity of ongoing anti-cancer treatments and increasing the therapeutic potential of innovative antitumor drugs. This evidence concerns the gene STAT3 and cancer.